4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Bizily Scott sold 3,270 4d Molecular Therapeutics, Inc. shares (Form 4)
Traded Aug 13 to Aug 17, 2026 · Filed Aug 17, 2026
From Aug 13 to Aug 17, 2026, Bizily Scott (Chief Legal Officer) sold 3,270 4d Molecular Therapeutics, Inc. shares at an average US$12.10 for US$39,567 under a trading plan, leaving 8,617 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 3,270 shares
- Price
- US$12.10 average (US$12.00 to US$12.20)
- Value
- US$39,567
- Holding after
- 8,617 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | Option exercise | 1,635 | US$4.14 | 10,252 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 1,635 | US$12.00 | 8,617 | Direct |
| Aug 17, 2026 | Common Stock | Option exercise | 1,635 | US$4.14 | 10,252 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 1,635 | US$12.20 | 8,617 | Direct |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Bizily Scott
- 4d Molecular Therapeutics, Inc. shareholders
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Bizily Scott · Sep 3, 2026
- Form 4 · Bizily Scott · Jul 2, 2026
- Form 4 · Bizily Scott · Jun 25, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Kirn David · Aug 21, 2026
- Form 4 · Kirn David · Aug 5, 2026
- Form 4 · Kirn David · Aug 4, 2026